ImmunityBio, Inc.IBRXNASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$14.74M
↑ 1165% above average
Average (9y)
$1.17M
Historical baseline
Range
High:$14.74M
Low:$-8.97M
CAGR
+58.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $14.74M | +2270.6% |
| 2023 | $622000.00 | +159.2% |
| 2022 | $240000.00 | -74.3% |
| 2021 | $934000.00 | +54.4% |
| 2020 | $605000.00 | +106.7% |
| 2019 | $-8.97M | -384.1% |
| 2018 | $3.16M | +6915.6% |
| 2017 | $45000.00 | +2.3% |
| 2016 | $44000.00 | -81.4% |
| 2015 | $236000.00 | - |